3149 results for «402»
3149 results
Complications and bailout strategies in transcatheter mitral interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses complications encountered during transcatheter mitral valve edge-to-edge repair (TEER), focusing on their identification, management, and prevention. Through case studies and interactive discussions, participants gain insights into optimizing case selection and implementing effective bailout strategies to ensure procedural safety.
The next generation DES technology: innovative DES+DCB stent platform
Next generation of DES technology, what it's all about? Find out in this session where experts will present complex cases from around the world and discuss the new indications for which they can be used.
Newly emerging devices from Asia and upcoming trials on new TAVI frontier
14 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights newly emerging transcatheter aortic valve implantation (TAVI) devices from Asia and presents ongoing and upcoming clinical trials exploring innovative TAVI frontiers. It provides insights into the evolving device landscape and evidence shaping future directions in TAVI therapy.
Team approach to structural heart disease: how to handle unexpected situations
14 Feb 2026 – From PCR Tokyo Valves 2026
This session emphasizes the importance of a multidisciplinary team approach in managing unexpected events during structural heart disease interventions. Through real-world examples, it highlights the roles and responses of radiologic technologists, clinical engineers, sonographers, and nursing staff in effectively addressing intraoperative complications and postoperative challenges to...
Procedural optimisation for enhanced acute and long-term outcomes
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delves into procedural optimization techniques for transcatheter aortic valve implantation (TAVI) to enhance both acute and long-term outcomes. It discusses critical procedural factors such as valve sizing, expansion, implantation depth, and commissural alignment, and their role in valve durability and survival. Practical cathlab cases...
Patient selection for tricuspid TEER in 2026
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delineates criteria for optimal patient selection for tricuspid transcatheter edge-to-edge repair (TEER) in 2026. Integrating anatomical, haemodynamic, and clinical parameters, it clarifies the evolving indications relative to transcatheter tricuspid valve replacement (TTVR) and conservative management. Real-world cases informed by pivotal trials such as TRILUMINATE,...
Transcatheter valve-in-valve intervention: LIVE Educational Case from The Prince Charles Hospital, Metro North Health - Brisbane, Australia
14 Feb 2026 – From PCR Tokyo Valves 2026
Experience a live educational case on transcatheter valve-in-valve intervention highlighting anatomical challenges, the critical role of pre-procedural CT imaging, and meticulous planning to prevent life-threatening complications and achieve favorable long-term outcomes.
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
